ATE253113T1 - Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür - Google Patents

Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür

Info

Publication number
ATE253113T1
ATE253113T1 AT95917601T AT95917601T ATE253113T1 AT E253113 T1 ATE253113 T1 AT E253113T1 AT 95917601 T AT95917601 T AT 95917601T AT 95917601 T AT95917601 T AT 95917601T AT E253113 T1 ATE253113 T1 AT E253113T1
Authority
AT
Austria
Prior art keywords
nucleic acid
activation protein
fibroblast activation
acid encoding
alpha
Prior art date
Application number
AT95917601T
Other languages
English (en)
Inventor
Wolfgang J Rettig
Matthew J Scanlan
Pilar Garin-Chesa
Lloyd J Old
Original Assignee
Ludwig Inst Cancer Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ludwig Inst Cancer Res filed Critical Ludwig Inst Cancer Res
Application granted granted Critical
Publication of ATE253113T1 publication Critical patent/ATE253113T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70517—CD8
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95917601T 1994-04-20 1995-04-19 Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür ATE253113T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/230,491 US5587299A (en) 1994-04-20 1994-04-20 Isolated nucleic acid molecule coding for fibroblast activation protein alpha and uses thereof
PCT/US1995/004860 WO1995029233A1 (en) 1994-04-20 1995-04-19 ISOLATED NUCLEIC ACID MOLECULE CODING FOR FIBROBLAST ACTIVATION PROTEIN α AND USES THEREOF

Publications (1)

Publication Number Publication Date
ATE253113T1 true ATE253113T1 (de) 2003-11-15

Family

ID=22865438

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95917601T ATE253113T1 (de) 1994-04-20 1995-04-19 Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür

Country Status (7)

Country Link
US (1) US5587299A (de)
EP (1) EP0763105B1 (de)
JP (1) JPH10504443A (de)
AT (1) ATE253113T1 (de)
AU (1) AU685273B2 (de)
DE (1) DE69532033T2 (de)
WO (1) WO1995029233A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5767242A (en) * 1994-04-20 1998-06-16 Boehringer Ingelheim Int'l Gmbh Isolated dimeric fibroblast activation protein alpha, and uses thereof
US6979697B1 (en) * 1998-08-21 2005-12-27 Point Therapeutics, Inc. Regulation of substrate activity
US6890904B1 (en) 1999-05-25 2005-05-10 Point Therapeutics, Inc. Anti-tumor agents
AU2001256325A1 (en) * 2000-03-17 2001-09-24 Boehringer Ingelheim Pharma Kg Human and humanized fap-alpha-specific antibodies
WO2004001004A2 (en) * 2002-06-21 2003-12-31 Johns Hopkins University School Of Medicine Membrane associated tumor endothelium markers
IL166157A0 (en) * 2002-07-09 2006-01-15 Point Therapeutics Inc Methods and compositions relating to isoleucine boroproline compounds
JP2004173695A (ja) * 2002-11-25 2004-06-24 F Hoffmann La Roche Ag Ｄｐｐ−ｉｖの結晶構造およびその使用方法
US7309774B2 (en) * 2003-02-07 2007-12-18 The Board Of Regents Of The University Of Oklahoma Antiplasmin cleaving enzyme
US20080057491A1 (en) * 2003-02-07 2008-03-06 Mckee Patrick A Substrates and inhibitors of antiplasmin cleaving enzyme and methods of use
US20090238862A1 (en) * 2004-10-27 2009-09-24 Wen-Tien Chen Methods and Compositions for Seprase Inactivation
US8067248B2 (en) 2005-12-14 2011-11-29 Luwig Institute for Cancer Research Method for diagnosing rheumatoid arthritis via assaying myofibroblast-like synoviocytes for fibroblast activation protein
US8933201B2 (en) 2006-06-07 2015-01-13 The Board Of Regents Of The University Of Oklahoma Substrates and inhibitors of antiplasmin cleaving enzyme and fibroblast activation protein and methods of use
EP2483316A1 (de) 2009-10-02 2012-08-08 Ludwig Institute for Cancer Research Ltd. Anti-fibroblastenaktivierungsprotein-antikörper, verfahren und verwendung
WO2011040973A2 (en) 2009-10-02 2011-04-07 Ludwig Institute For Cancer Research Ltd. Tnf-immunoconjugates with fibroblast activation protein antibodies and methods and uses thereof
CN103267852B (zh) * 2013-05-15 2015-03-25 中国医学科学院北京协和医院 成纤维激活蛋白α在制备胰腺癌预后试剂盒中的用途
CA3034517A1 (en) 2016-08-29 2018-03-08 Psioxus Therapeutics Limited Adenovirus armed with bispecific t cell activator
GB201713765D0 (en) 2017-08-28 2017-10-11 Psioxus Therapeutics Ltd Modified adenovirus

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008114A1 (en) * 1988-02-25 1989-09-08 The General Hospital Corporation Rapid immunoselection cloning method
CA2075259A1 (en) * 1991-08-26 1993-02-27 Junsheng Sang Expression cloning method
WO1993005804A1 (en) * 1991-09-18 1993-04-01 Sloan-Kettering Institute For Cancer Research Activated stromal fibroblast-specific antibody, f19 and methods of using the same

Also Published As

Publication number Publication date
AU685273B2 (en) 1998-01-15
EP0763105B1 (de) 2003-10-29
AU2359495A (en) 1995-11-16
DE69532033T2 (de) 2004-07-08
EP0763105A4 (de) 1999-10-27
DE69532033D1 (de) 2003-12-04
JPH10504443A (ja) 1998-05-06
EP0763105A1 (de) 1997-03-19
WO1995029233A1 (en) 1995-11-02
US5587299A (en) 1996-12-24

Similar Documents

Publication Publication Date Title
ATE253113T1 (de) Für ein fibroblasten-aktivierungsprotein kodierende nukleinsäure und verwendungen dafür
FI962247A (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden käyttömenetelmät
ATE394484T1 (de) Smad 6 und dessen anwendungen
ATE460429T1 (de) Polypeptide enthaltend extrazellulären domäne von il-20ra und/oderr il-20rb
DE69736068D1 (de) Faktor viii vom schwein und hybriden
DE69739665D1 (de) Isoliertes, dimerisches fibroblasten-aktivierendes protein alpha und anwendungen desselben
NO971875D0 (no) Cathepsin 02 protease
FI885504A0 (fi) Vaskulaera antikoagulerande proteiner, dessa koderande dna, deras framstaellningsfoerfarande och deras anvaendning.
ATE534742T1 (de) Polypeptide und nukleinsäuren von phorphorymonas gingivalis
BR9710919A (pt) Proteina purificada sr-p70
EP1117682A4 (de) Peptide
DK0942992T3 (da) O-fucosyltransferase
ATE380245T1 (de) Gen von alteromonas
CA2188264A1 (en) Isolated nucleic acid molecule coding for fibroblast activation protein .alpha. and uses thereof
DE69809930D1 (de) Isolierung und verwendung von nukleinsäuremolekülen, welche für mitglieder der ssx-familie kodieren
ATE215123T1 (de) Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
DE69033553T2 (de) Rekombinante herstellung von laktoperoxidase
ATE412753T1 (de) Antibakterielles protein chlamysin-b, dafür kodierendes gen und ein expresionssystem dafür
BR9915537A (pt) Gene prv-1 e sua utilização
ITRM950434A0 (it) Polipeptide per la riparazione di informazione genetica, sequenza nucleotidica che codifica per esso e procedimento per la sua preparazione.
WO2002038765A3 (en) Dna encoding bovine immunoglobulin a inducing protein and uses therefor
DE69519654D1 (de) htFIIIA Gen
ATE213268T1 (de) Fanconi-gen ii
ECSP972331A (es) Muteinas de la obesidad
ZA973515B (en) Flea protease proteins, nucleic acid molecules, and uses thereof.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0763105

Country of ref document: EP